Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. The Company's subsidiary, Harvest Medicine provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Comment by mdjbrownon Nov 20, 2022 10:23am
110 Views
Post# 35113649

RE:RE:RE:RE:Market

RE:RE:RE:RE:MarketS1 that is a real possibility.  Based on Fridays close, at 4:00 pm Scotia dumped half a million shares into the bid which drove the price down close to the lowest share price in the corporations history.

It cant be a short interest as shorting at .065 would be a dangerous risk / reward strategy, and with the recent positive updates and potential upcoming positive announcements, why would anyone dump that many shares at market close on a Friday clearly taking a loss?

This upcoming week should get very interesting as President Bidens approval of the Medical Marijuana and Cannabidol research Expansion Act could signal a major victory for Medipharm considering Labs has been positioning themselves for exactly that    -  a seat at a very lucrative US table..........

 https://www.politico.com/news/2022/11/16/congress-sends-first-weed-bill-to-biden-00068082

 



<< Previous
Bullboard Posts
Next >>